Evidence map›Paper›PMID 38068071›Full record

ReviewMaterials (Basel, Switzerland)2023

Recent Developments in Ultrafine Shape Memory Alloys Using Amorphous Precursors.

Sung-Hwan Hong, Hae-Jin Park, Gi-An Song, Ki-Buem Kim

Abstract readReview
In one paragraph

Review in Materials (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sung-Hwan HongDepartment of Nanotechnology and Advanced Materials Engineering, Sejong University, Seoul 05006, Republic of Korea.ORCID 0000-0001-8441-4013
Hae-Jin ParkDepartment of Nanotechnology and Advanced Materials Engineering, Sejong University, Seoul 05006, Republic of Korea.
Gi-An SongDivision of Advanced Materials Engineering, Kongju National University, Cheonan-si 31080, Republic of Korea.
Ki-Buem KimDepartment of Nanotechnology and Advanced Materials Engineering, Sejong University, Seoul 05006, Republic of Korea.ORCID 0000-0002-6180-2715

Funding

National Research Foundation of Korea 2021R1C1C1006279National Research Foundation of Korea RS-2023-00209325
6 · The paper itself

Abstract

In this review, we systematically reviewed the recent advances in the development of ultrafine shape memory alloys with unique shape memory effects and superelastic behavior using amorphous metallic materials. Its scientific contribution involves defining and expanding the range of fabrication methods for single-phase ultrafine/nanocrystalline alloys with multicomponent systems. In multicomponent amorphous alloys, the crystallization mechanism depends on the alloy composition and is a selectable factor in the alloy designing method, considering the thermodynamic and physical parameters of constituent elements. The crystallization kinetics can be controlled by modulating the annealing condition in a supercooled liquid state with consideration of the crystalline temperature of the amorphous alloys. The phase stability of austenite and martensite phases in ultrafine shape memory alloys developed from amorphous precursors is determined according to alloy composition and grain size, which strongly influence the shape memory effect and superelastic behavior. A methodological framework is subsequently suggested to develop the ultrafine shape memory alloys based on the systematic alloy designing method, which can be considered an important strategy for developing novel ultrafine/nanocrystalline shape memory alloys with excellent shape memory and superelastic effects.

Indexed as

amorphous precursorcrystallization kineticsshape memory alloyshape memory effectsuperelasticity

Identifiers

PMID38068071
PMCPMC10707266

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.